Purple Biotech Ltd. (PPBT)
1.64
-0.01
(-0.61%)
USD |
NASDAQ |
Aug 26, 12:58
Purple Biotech Debt to Equity Ratio : 0.0109 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0109 |
| March 31, 2026 | 0.0189 |
| December 31, 2025 | 0.0251 |
| September 30, 2025 | 0.0078 |
| June 30, 2025 | 0.0032 |
| March 31, 2025 | 0.0042 |
| December 31, 2024 | 0.0056 |
| September 30, 2024 | 0.0075 |
| June 30, 2024 | 0.0089 |
| March 31, 2024 | 0.0099 |
| December 31, 2023 | 0.0103 |
| September 30, 2023 | 0.0096 |
| June 30, 2023 | 0.0099 |
| March 31, 2023 | 0.01 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.011 |
| September 30, 2022 | 0.0106 |
| June 30, 2022 | 0.0107 |
| March 31, 2022 | 0.012 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 3.282 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | -0.9482 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Teva Pharmaceutical Industries Ltd. | 2.176 |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 0.2676 |
| Sol-Gel Technologies Ltd. | 0.016 |
| PolyPid Ltd. | 0.2918 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 14.17M |
| Total Liabilities (Quarterly) | 1.953M |
| Shareholders Equity (Quarterly) | 12.27M |
| Current Ratio | 3.696 |
| Net Debt Paydown Yield | 0.02% |